Christy Cotner
About
Christy A. Cotner, DNP, FNP-C, is a family nurse practitioner based in Corona, California. Her published research spans several clinically distinct areas, including psychiatric pharmacotherapy, serious illness communication in oncology, and precision medicine approaches to treatment-resistant depression. That breadth reflects a practice orientation that draws on both primary care and complex chronic disease management.
Cotner has contributed to peer-reviewed literature in journals including the Journal of the American Association of Nurse Practitioners, The Nurse Practitioner, the Journal of Pain and Symptom Management, JCO Oncology Practice, and the New England Journal of Medicine, with 18 publications in total. Her recent work includes a comprehensive review of pharmacotherapy for bipolar major depression, a case series on pharmacogenomic approaches to treatment-resistant depression, and qualitative research examining barriers to serious illness conversations among patients with advanced cancer. She has also contributed to research on multi-cancer detection tests and on the role of complete blood count components as diagnostic biomarkers in major depressive disorder. She is licensed in California.
Credentials
Publications
- Bipolar major depression: A comprehensive review of pharmacotherapy.
- The role of complete blood count components as diagnostic biomarkers in major depressive disorder.
- Precision medicine in psychiatry: Case series on pharmacogenomic solutions for treatment-resistant depression.
- Barriers to Serious Illness Conversations Among Patients with Advanced Cancer: A Qualitative Study.
- Two Sides to the Story.
- Using Oncology Treatment Pathway Data to Evaluate Serious Illness Communication, Care Utilization, and End-of-Life Care for Patients With Cancer.
- Understanding the Landscape of Multi-Cancer Detection Tests: The Current Data and Clinical Considerations.
- Assessing the Impact of the COVID-19 Pandemic on Geographic Residency Placement Relative to Medical School Location.
- Automated Text-Based Symptom Monitoring With Rapid Clinician Triage for Patients With Cancer and Suspected or Confirmed COVID-19.
- Surveillance of postchemotherapy subcentimeter residual retroperitoneal mass in metastatic nonseminomatous germ cell tumor: Does how you measure matter?
Request CV and rates
Tell us about your case and we'll connect you with Christy Cotner within two business days.
Other Primary Care experts
Verified specialists available for your case.
